Affiliation: Beth Israel Medical Center
- Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II)Henry Greenberg
Cardiology Division, Department of Medicine, St Luke s Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, New York 10019, USA
J Am Coll Cardiol 43:1459-65. 2004..The purpose of this study was to determine the efficacy of implantable cardiac defibrillator (ICD) therapy in preventing sudden cardiac death (SCD) in post-infarction patients with advanced left ventricular (LV) dysfunction...
- Sudden cardiac death. An essay for 2008Henry Greenberg
Division of Cardiology, St. Luke's Roosevelt Hospital, New York, NY 10019, USA
Prog Cardiovasc Dis 50:384-9. 2008
- Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarctionArthur J Moss
Cardiology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
Am J Cardiol 96:177-82. 2005....
- Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunctionIlan Goldenberg
Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA
Am J Cardiol 98:485-90. 2006..Defibrillator therapy was associated with a significant survival benefit among the study patients with mild to moderate or no renal disease, but no benefit was shown among patients with more advanced renal dysfunction...
- Cardiac-resynchronization therapy for the prevention of heart-failure eventsArthur J Moss
Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
N Engl J Med 361:1329-38. 2009....
- Reduction in inappropriate therapy and mortality through ICD programmingArthur J Moss
Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642 0653, USA
N Engl J Med 367:2275-83. 2012..The implantable cardioverter-defibrillator (ICD) is highly effective in reducing mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are frequent, with potential adverse effects...
- Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II)Ritesh Dhar
Institute for Clinical Research and Health Policy Studies, Department of Medicine, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
Heart Rhythm 5:807-13. 2008..There is conflicting literature on the relationship between prolonged QRS duration (QRSd) and arrhythmic events, including sudden cardiac death (SCD), in heart failure patients with or without implantable cardioverter-defibrillators (ICDs)...
- Temporal aspects of improved survival with the implanted defibrillator (MADIT-II)Arthur J Moss
Heart Research Follow Up Program, Cardiology Unit, Department of Medicine, University of Rochester Medical Center, New York 14642, USA
Am J Cardiol 94:312-5. 2004..In the early period, the rate of nonsudden cardiac death was significantly higher in the ICD group than in the conventional therapy group (p = 0.003). Rates of late nonsudden cardiac death were similar in the 2 treatment arms (p = 0.11)...
- Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trialAysha Arshad
Cardiology Division, St Luke s and Roosevelt Hospitals and Columbia University, New York, New York, USA
J Am Coll Cardiol 57:813-20. 2011....
- Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarctionTareq S Harb
Cardiology Unit of the Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
Am J Cardiol 89:216-21. 2002
- Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillatorArthur J Moss
Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
Circulation 110:3760-5. 2004..This analysis from the MADIT-II trial database examines the long-term clinical course and subsequent mortality risk of patients after termination of life-threatening ventricular tachyarrhythmias by an ICD...